Press coverage about Kindred Healthcare (NYSE:KND) has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Kindred Healthcare earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news headlines about the health services provider an impact score of 46.4422453481464 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Here are some of the news headlines that may have effected Accern Sentiment’s analysis:

Kindred Healthcare (NYSE:KND) traded up 1.38% during trading on Friday, reaching $7.35. 1,229,855 shares of the company were exchanged. The stock’s market capitalization is $639.59 million. Kindred Healthcare has a 1-year low of $5.65 and a 1-year high of $11.90. The company’s 50-day moving average price is $10.24 and its 200-day moving average price is $9.20.

Kindred Healthcare (NYSE:KND) last released its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The firm’s quarterly revenue was down 4.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.38 EPS. On average, equities analysts forecast that Kindred Healthcare will post $0.57 EPS for the current year.

A number of research firms recently issued reports on KND. UBS AG reissued a “neutral” rating and issued a $10.50 price target (up from $8.00) on shares of Kindred Healthcare in a research note on Friday, May 5th. Zacks Investment Research downgraded shares of Kindred Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, May 5th. Mizuho reissued a “neutral” rating and issued a $9.00 price target on shares of Kindred Healthcare in a research note on Monday, July 3rd. Royal Bank Of Canada reissued a “hold” rating and issued a $10.00 price target on shares of Kindred Healthcare in a research note on Monday, May 15th. Finally, BidaskClub downgraded shares of Kindred Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $9.94.

ILLEGAL ACTIVITY WARNING: This report was published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.dailypolitical.com/2017/08/13/kindred-healthcare-nyseknd-receiving-somewhat-positive-press-coverage-report-finds.html.

About Kindred Healthcare

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Insider Buying and Selling by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.